PlainRecalls

Gilead Sciences, Inc.

Compiled from official public sources by the publisher.

7 recalls on record · Latest: Oct 9, 2024

Subscribe to new Gilead Sciences, Inc. recalls (RSS)

Agency notice ledger

Federal filing book Gilead Sciences, Inc. LIGHT-BOOK · SINGLE-AGENCY

#1,931 of 14,151 · 7 notices · 0.007% archive

  • BOOK 7 notices
  • RANK #1,931 of 14,151
  • SHARE 0.007% archive
  • AGENCY FDA Drug (7)
  • CAT drugs
  • CATS 1 category
  • LATEST Oct 9, 2024
  • PHOTO Abbott Diagnostics Sc…

Nearest notice-volume peer: Abbott Diagnostics Scarborough, Inc. (0 notice gap)

Gilead Sciences, Inc. accounts for about 0.007% of the 104,423-notice archive on 7 distinct filings — a mid share signal beside absolute volume. FDA · CPSC · USDA FSIS · NHTSA notice stamps for this firm. Read with this firm → · Dominant category → · Similar-volume firm →

Where Gilead Sciences, Inc. sits among 14,151 recalling firms

Gilead Sciences, Inc. ranks 1,931st of 14,151 tracked firms by distinct recall-event count. Archive size reflects filing volume, not inherent product danger.

Gilead Sciences, Inc. vs all firms by recall-notice count

Where this firm's archive sits among every tracked recalling manufacturer

7 1931st of 14151 higher than 12,091 of 14,151 firms

Firms, banded by distinct federal recall-event inventory

Each bar is a band; taller bars hold more firms. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source FDA · CPSC · USDA FSIS · NHTSA federal recall filings · 2026-09-13

Gilead Sciences, Inc. in the notice-volume neighbourhood

Distinct federal recall events among this firm and nearest nationwide peers

notices

What this shows Gilead Sciences, Inc. holds about 0.007% of archive notices alongside 7 distinct filings.

Source FDA · CPSC · USDA FSIS · NHTSA filings aggregated by PlainRecalls As of September 2026
FDA Drug Critical Oct 9, 2024

Veklury (remdesivir) for injection, 100 mg/vial, Single-Dose Vial, Rx only, Manufactured for: Gilead Sciences, Inc., Foster City, CA 94404, NDC 61958-2901-2
FDA Drug Critical Jan 5, 2022

Veklury (remdesivir) for injection, 100 mg/vial, Single-Dose Vial, Rx only, Manufactured for: Gilead Sciences, Inc., Foster City, CA 94404, NDC 61958-2901-2
FDA Drug Moderate Nov 5, 2014

Emtriva (emtricitabine) Oral Solution, 10 mg/mL, 170 mL bottles, Rx only, Manufactured for Gilead Sciences, Inc., Foster City, CA NDC 61958-0602-1 Gilead Sciences, Inc. Foster City, CA 94404.
FDA Drug Low Oct 15, 2014

Truvada (200 mg emtricitabine and 300 mg tenofovir disoproxil fumarate) tablets, 30 count bottles, Rx only, Manufactured for Gilead Sciences, Inc. Foster City, CA 94404, NDC 61958-0701-1
FDA Drug Low Mar 5, 2014

Atripla (efavirenz 600 mg/ emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg) Tablets, 30 Tablet Bottles, Rx only. Manufactured for: Bristol-Myers Squibb & Gilead Sciences, LLC, Foster City, CA 94404. Made in Ireland. NDC 15584-0101-1. Manufactured for: Bristol-Myers-Squibb & Gilead Sciences, LLC, Foster City, CA 94404 Made in Ireland
FDA Drug Moderate Jul 31, 2013

AmBisome (amphotericin B) liposome for Injection, 50 mg, For Intravenous Infusion Only, Single-Use Vial, Rx Only, Marketed by: Astellas Pharma US, Inc., Northbrook, IL 60062, Manufactured by: Gilead Sciences, Inc., San Dimas, CA 91773, NDC 0469-3051-30.
FDA Drug Critical May 22, 2013

Vistide (cidofovir) Injection, 375 mg (75 mg/mL), 5 mL single-use vial, Rx only, Manufactured for: Gilead Sciences, Inc., Foster City, CA 94404, UPC 3 61958 01011 5; NDC 61958-0101-1.

Gilead Sciences, Inc. holds a measurable archive slice

Drug and device firms outside this manufacturer and state, matched by notice volume and category footprint.

Frequently Asked Questions

How many federal recall notices name Gilead Sciences, Inc.? ▼
PlainRecalls indexes 7 distinct federal recall events naming Gilead Sciences, Inc., aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (archive as of September 2026). That count is an issuance inventory, not a hazard score.
Where does Gilead Sciences, Inc. sit among other recalling firms? ▼
Gilead Sciences, Inc. ranks #1,931 of 14,151 by distinct recall-event count among 14,151 firms in this archive (85th percentile of firms with fewer notices). Rank tracks filing frequency, not product danger.
Which agency issues most of Gilead Sciences, Inc.'s notices? ▼
FDA Drug accounts for 7 of this firm's 7 indexed notices.
What product category dominates Gilead Sciences, Inc.'s filing book? ▼
Filings for Gilead Sciences, Inc. span 1 product category, led by drugs. Browse that category archive for peer firms and related notices.
Is a higher notice count more dangerous? ▼
No. Archive size reflects how often federal agencies publish recalls naming the firm — reporting volume, coverage, and product range all move the number. Always verify the individual notice with the issuing agency before acting on a specific product.
Gilead Sciences, Inc.: 7 federal recall notices aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (lead agency FDA Drug). Verify individual notices with FDA directly before acting on a specific recall.

Firm-level totals aggregate distinct federal recall events naming Gilead Sciences, Inc.; individual notices remain authoritative on each linked recall page.

Methodology · Corrections · FDA · CPSC · USDA FSIS · NHTSA · Archive as of September 2026